Avicanna Supports University of Calgary Trial on Oral THC Dosing for Anxiety
This article covers oral THC dosing anxiety research sponsored by Avicanna at the University of Calgary. The clinical trial aims to establish safe and effective oral THC dosing guidelines for anxiety treatment. Understanding dose-dependent effects is…
Evil Kermit
When your patient asks if cannabis will cure their condition versus when you explain the actual evidence for symptom management. The difference between hope and realistic therapeutic goals. Further Reading Research DigestAM Policy Update: March 16, 2026…
This Week in Cannabis: Clinical Research & Therapeutic Applications
This week’s roundup highlights cannabis clinical research therapeutic applications, including dose-finding trials and safety monitoring studies. Regulatory developments and commercial testing technology advances are also covered. Stay informed on the…
Cannabix Technologies Launches Marijuana Breath Test (MBT)
Marijuana breath test technology offers a rapid, non-invasive method to detect recent cannabis use within a 4-hour window. This innovation aids clinicians and employers in assessing recent cannabis exposure more accurately. The breath test technology…
Avicanna Sponsors University of Calgary THC Dose Finding Clinical Trial
Avicanna sponsors a THC dosing clinical trial at the University of Calgary to establish safe and effective therapeutic windows. This clinical trial aims to provide evidence-based dosing guidelines for THC. The study is essential for clinicians to improve…
Driving Habits and Cannabis Use Among Teens and Young Adults
Cannabis use among teen drivers raises important safety concerns for clinicians and parents. This article reviews the prevalence and risks of cannabis use among teen drivers. Understanding cannabis use among teen drivers is critical for effective…
Takeaways from the 2026 South Dakota Legislative Session
The 2026 South Dakota medical marijuana oversight committee has expanded to include diverse professional representation. This change aims to improve governance and clinical application of cannabis policy. Clinicians should monitor these updates to…
Missouri Cannabis Rules Change to Address Microbusiness Fraud
Missouri cannabis microbusiness licensing has been updated to address fraud concerns affecting product safety. These regulatory changes impact clinicians' ability to recommend legitimate cannabis products. Understanding these licensing rules is essential…
Virginia Cannabis Sales Legalization Bill Heads to Governor (Newsletter: March 16, 2026)
Virginia cannabis legalization impact is reshaping healthcare provider practices and patient access. Clinicians must understand regulatory changes affecting cannabis use and safety. This evolving landscape requires updated clinical protocols and patient…
GLP-1s a Viable Option to Treat, Prevent SUDs? – Medscape
GLP-1 receptor agonists substance use disorders may provide clinicians with a novel pharmacological approach to treating addiction. Emerging evidence suggests these agents could reduce the risk of substance use disorders, including cannabis use disorder.…